lbe logo
clock icons Tuesday,
May 18th,
2 PM ET
PLEASE FILL IN THE FORM BELOW TO REGISTER FOR THE EVENT

Once you have submitted your details, you will receive an email containing the event URL and access information.

If you have any questions,
please contact: info@lungbioengineering.com

We are excited to share Lung Bioengineering’s (LBE) recent innovations and future aspirations with our OPO community in this special webinar.

During this event, our Regional Transplant Center and OPO Liaison, Ashley Brown, will explore the ways in which LBE is evolving, expanding and optimizing its centralized ex vivo lung perfusion (EVLP) service model to deliver a seamless experience for our OPO partners.

Following this presentation, we will hold an interactive discussion with Clint Hosteler, Vice President of Clinical Operations at LifeShare of Oklahoma, and Becky Shore, Transplant Program Manager at Spectrum Health, to provide a deeper insight into the advantages that LBE can bring to your organization.

MEET OUR SPEAKERS
ashley brown
Ashley Brown
Regional OPO Liaison,
Lung Bioengineering
BIO +
Becky Shore
Becky Shore
Transplant Program Manager,
Spectrum Health
BIO +
Clint Hosteler
Clint Hosteler
Vice President of Clinical
Operations, LifeShare of
Oklahoma
BIO +
2020
DID YOU KNOW
there were 3,224 DCD donors in 2020 and only 227 were also lung donors?1
2020
graph01

TOTAL LUNGS

2,577

DCD LUNG TRANSPLANTS

347

TOTAL DCD DONORS

3,224

TOTAL DCD LUNG DONORS

227


LUNG BIOENGINEERING HAS COMPLETED OVER 250 EVLPS
64% of lungs sent to LBE for EVLP to date have been accepted for transplant (167 lungs/262 donors). The majority of procedures were done as part of a clinical trial using an investigational EVLP device.
graph02

TOTAL DONOR LUNGS
(RECEIVED AT LB1 AND LB2)

262

EVLP LUNGS ACCEPTED
TO TRANSPLANT

167

PATIENTS TRANSPLANTED WITH EVLP LUNGS

171

BENEFITS OF OUR CENTRALIZED EVLP SERVICE
Learn more about the benefits that Lung Bioengineering’s centralized EVLP service model can bring to your organization and leverage innovation for the good of our wider transplant community.
01

ROBUST
EXPERIENCE

02

FLEXIBILITY

03

TRUSTWORTHY DATA

04

EXPANDED
DONOR POOL

05

REDUCED COST &
RESOURCES BURDEN

06

RISK MANAGEMENT

07

CONTINUOUS
LOGISTICAL
ASSISTANCE